Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy

The recent advances in the field of immuno-oncology have dramatically changed the therapeutic strategy against advanced malignancies. Bispecific antibody-based immunotherapies have gained momentum in preclinical and clinical investigations following the regulatory approval of the T cell–redirecting...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco, Belén, Domínguez-Alonso, Carmen, Alvarez-Vallina, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306338/
https://www.ncbi.nlm.nih.gov/pubmed/34108185
http://dx.doi.org/10.1158/1078-0432.CCR-20-3770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306338/
https://www.ncbi.nlm.nih.gov/pubmed/34108185
http://dx.doi.org/10.1158/1078-0432.CCR-20-3770

Ejemplares similares